Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built proteins known as DARPin® therapeutics, today announced that Patrick Amstutz, chief executive officer, will be presenting at the HC Wainwright 22nd Annual Global Investments Conference taking place September 14-16, 2020, as well as participating in a fireside chat at the Morgan Stanley Global Healthcare Conference taking place September 14-18, 2020.
Details for the presentations are as follows:
HC Wainwright 22nd Annual Global Investments Conference
Presentation Date: Monday, September 14, 2020
Presentation Time: 11:30 a.m. ET
Morgan Stanley Global Healthcare Conference
Presentation Date: Wednesday, September 16, 2020
Presentation Time: 1:15 p.m. ET
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
A webcast of the presentations will be available on the Molecular Partners website.